US Stock MarketDetailed Quotes

Tvardi Therapeutics (TVRD)

Watchlist
  • 3.960
  • +0.010+0.25%
Close May 14 16:00 ET
  • 3.960
  • 0.0000.00%
Post 16:10 ET
37.15MMarket Cap-1.64P/E (TTM)

Tvardi Therapeutics (TVRD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
23.80%-5.86M
-28.37%-23.5M
-17.63%-5.69M
36.03%-4.26M
-124.83%-5.87M
74.75%-7.69M
13.00%-18.31M
15.93%-4.83M
-6.66M
23.64M
Net income from continuing operations
28.97%-6.8M
38.04%-18.21M
42.75%-7.28M
-0.25%-5.53M
-78.65%4.17M
68.79%-9.58M
-69.46%-29.4M
-192.05%-12.71M
---5.51M
--19.52M
Depreciation and amortization
0.00%24K
0.00%95K
0.00%24K
0.00%24K
360.00%23K
-42.86%24K
0.00%95K
0.00%24K
--24K
--5K
Other non cash items
-96.52%20K
214.35%723K
-89.78%19K
20.00%18K
105.00%111K
-74.46%575K
350.98%230K
1,330.77%186K
--15K
---2.22M
Change In working capital
115.46%566K
-94.12%508K
-78.75%1.23M
172.48%914K
-77.51%2.03M
25.08%-3.66M
318.26%8.64M
480.13%5.78M
---1.26M
--9.01M
-Change in receivables
----
----
----
----
----
-122.17%-243K
----
----
----
----
-Change in inventory
----
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
138.51%382K
-109.73%-308K
5.28%1.26M
-60.57%153K
6.81%-725K
-141.96%-992K
210.39%3.17M
198.25%1.19M
--388K
---778K
-Change in payables and accrued expense
108.02%212K
-83.49%919K
--0
148.43%787K
-78.20%2.78M
73.95%-2.64M
652.28%5.57M
342.83%4.61M
---1.63M
--12.73M
-Change in other current liabilities
-16.67%-28K
-10.75%-103K
-16.67%-28K
-8.33%-26K
---25K
---24K
-13.41%-93K
-9.09%-24K
---24K
----
Cash from discontinued investing activities
Operating cash flow
23.80%-5.86M
-28.37%-23.5M
-17.63%-5.69M
36.03%-4.26M
-124.83%-5.87M
74.75%-7.69M
13.00%-18.31M
15.93%-4.83M
---6.66M
--23.64M
Investing cash flow
Cash flow from continuing investing activities
145.72%4.98M
-10.08M
5M
5.35M
63.20%-9.55M
-141.94%-10.88M
0
0
0
-25.95M
Net PPE purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
145.72%4.98M
---10.08M
--5M
--5.35M
64.35%-9.55M
-140.63%-10.88M
--0
--0
--0
---26.79M
Cash from discontinued investing activities
Investing cash flow
145.72%4.98M
---10.08M
--5M
--5.35M
63.20%-9.55M
-141.94%-10.88M
--0
--0
--0
---25.95M
Financing cash flow
Cash flow from continuing financing activities
0
-15.91%22.7M
-100.00%1K
-2,200.00%-322K
3,469.13%24.63M
-134.01%-1.6M
1,349,900.00%27M
27.01M
-14K
690K
Net issuance payments of debt
----
--0
----
----
----
----
--28.3M
----
----
----
Net common stock issuance
--0
10,540.00%532K
--1K
--107K
--421K
--3K
150.00%5K
--0
--0
----
Net other financing activities
----
1,801.53%22.17M
--0
---429K
--24.21M
-134.45%-1.61M
---1.3M
---1.29M
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-15.91%22.7M
-100.00%1K
-2,200.00%-322K
3,469.13%24.63M
-134.01%-1.6M
1,349,900.00%27M
--27.01M
---14K
--690K
Net cash flow
Beginning cash position
-34.42%20.73M
37.94%31.61M
126.93%21.42M
28.19%20.65M
-76.41%11.44M
-41.11%31.61M
6.65%22.92M
-67.08%9.44M
--16.11M
--48.5M
Current changes in cash
95.62%-883K
-225.13%-10.88M
-103.08%-684K
111.55%770K
666.71%9.21M
-288.95%-20.18M
508.04%8.7M
485.74%22.18M
---6.67M
---1.63M
End cash Position
73.54%19.85M
-34.42%20.73M
-34.42%20.73M
126.93%21.42M
28.19%20.65M
-76.41%11.44M
37.94%31.61M
37.94%31.61M
--9.44M
--16.11M
Free cash flow
23.80%-5.86M
-28.37%-23.5M
-17.63%-5.69M
36.03%-4.26M
-123.98%-5.87M
75.43%-7.69M
13.00%-18.31M
15.93%-4.83M
---6.66M
--24.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 23.80%-5.86M-28.37%-23.5M-17.63%-5.69M36.03%-4.26M-124.83%-5.87M74.75%-7.69M13.00%-18.31M15.93%-4.83M-6.66M23.64M
Net income from continuing operations 28.97%-6.8M38.04%-18.21M42.75%-7.28M-0.25%-5.53M-78.65%4.17M68.79%-9.58M-69.46%-29.4M-192.05%-12.71M---5.51M--19.52M
Depreciation and amortization 0.00%24K0.00%95K0.00%24K0.00%24K360.00%23K-42.86%24K0.00%95K0.00%24K--24K--5K
Other non cash items -96.52%20K214.35%723K-89.78%19K20.00%18K105.00%111K-74.46%575K350.98%230K1,330.77%186K--15K---2.22M
Change In working capital 115.46%566K-94.12%508K-78.75%1.23M172.48%914K-77.51%2.03M25.08%-3.66M318.26%8.64M480.13%5.78M---1.26M--9.01M
-Change in receivables ---------------------122.17%-243K----------------
-Change in inventory ----------------------0----------------
-Change in prepaid assets 138.51%382K-109.73%-308K5.28%1.26M-60.57%153K6.81%-725K-141.96%-992K210.39%3.17M198.25%1.19M--388K---778K
-Change in payables and accrued expense 108.02%212K-83.49%919K--0148.43%787K-78.20%2.78M73.95%-2.64M652.28%5.57M342.83%4.61M---1.63M--12.73M
-Change in other current liabilities -16.67%-28K-10.75%-103K-16.67%-28K-8.33%-26K---25K---24K-13.41%-93K-9.09%-24K---24K----
Cash from discontinued investing activities
Operating cash flow 23.80%-5.86M-28.37%-23.5M-17.63%-5.69M36.03%-4.26M-124.83%-5.87M74.75%-7.69M13.00%-18.31M15.93%-4.83M---6.66M--23.64M
Investing cash flow
Cash flow from continuing investing activities 145.72%4.98M-10.08M5M5.35M63.20%-9.55M-141.94%-10.88M000-25.95M
Net PPE purchase and sale ----------------------0----------------
Net investment purchase and sale 145.72%4.98M---10.08M--5M--5.35M64.35%-9.55M-140.63%-10.88M--0--0--0---26.79M
Cash from discontinued investing activities
Investing cash flow 145.72%4.98M---10.08M--5M--5.35M63.20%-9.55M-141.94%-10.88M--0--0--0---25.95M
Financing cash flow
Cash flow from continuing financing activities 0-15.91%22.7M-100.00%1K-2,200.00%-322K3,469.13%24.63M-134.01%-1.6M1,349,900.00%27M27.01M-14K690K
Net issuance payments of debt ------0------------------28.3M------------
Net common stock issuance --010,540.00%532K--1K--107K--421K--3K150.00%5K--0--0----
Net other financing activities ----1,801.53%22.17M--0---429K--24.21M-134.45%-1.61M---1.3M---1.29M--------
Cash from discontinued financing activities
Financing cash flow --0-15.91%22.7M-100.00%1K-2,200.00%-322K3,469.13%24.63M-134.01%-1.6M1,349,900.00%27M--27.01M---14K--690K
Net cash flow
Beginning cash position -34.42%20.73M37.94%31.61M126.93%21.42M28.19%20.65M-76.41%11.44M-41.11%31.61M6.65%22.92M-67.08%9.44M--16.11M--48.5M
Current changes in cash 95.62%-883K-225.13%-10.88M-103.08%-684K111.55%770K666.71%9.21M-288.95%-20.18M508.04%8.7M485.74%22.18M---6.67M---1.63M
End cash Position 73.54%19.85M-34.42%20.73M-34.42%20.73M126.93%21.42M28.19%20.65M-76.41%11.44M37.94%31.61M37.94%31.61M--9.44M--16.11M
Free cash flow 23.80%-5.86M-28.37%-23.5M-17.63%-5.69M36.03%-4.26M-123.98%-5.87M75.43%-7.69M13.00%-18.31M15.93%-4.83M---6.66M--24.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More